D. Jones

发表

Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD.

C. Eaves, A. Kariminia, S. Ivison, 2018, Blood.

Quantitation of Human Cells that Produce Neutrophils and Platelets in Vivo Obtained from Normal Donors Treated with Granulocyte Colony-Stimulating Factor and/or Plerixafor.

C. Eaves, D. Knapp, P. Miller, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.